MAIA Biotechnology, Inc.MAIANYSE
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-15.73M
↓ 72% vs avg
Percentile
P0
Near historical low
Streak
6 yr
Consecutive declineContracting
Average
$-9.16M
Historical baseline
PeriodValueYoY Change
TTM$-15.73M-0.2%
2024$-15.70M-20.1%
2023$-13.07M-8.1%
2022$-12.10M-193.4%
2021$-4.12M-123.6%
2020$-1.84M-17.8%
2019$-1.57M-